Liam Simani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liam Simani has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anton Warshavsky
Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel
3 shared publications - Omer Jacob Ungar
Division of Otology/Neurotology, Department of Otolaryngology‐Head and Neck Surgery Toronto General Hospital, University Health Network Toronto Ontario Canada
3 shared publications - Ophir Handzel
Departments of Otolaryngology‐Head and Neck Surgery and Maxillofacial Surgery Tel Aviv Sourasky Medical Center Tel Aviv Israel
3 shared publications - Yahav Oron
Department of Otolaryngology—Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, affiliated to Grey School of Medicine Tel‐Aviv University Tel Aviv Israel
3 shared publications Gilad Horowitz
Department of Otolaryngology Head, Neck and Maxillofacial Surgery Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University Tel Aviv Israel
2 shared publicationsNidal Muhanna
Department of Otolaryngology Head, Neck and Maxillofacial Surgery Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University Tel Aviv Israel
2 shared publications
Latest Publications
- 30 July 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (11-12) , e2443-e2450
Training in the Shadow of War: Exertional Heat Illness During the “Iron Swords” War
Introduction: High-intensity physical exertion in combat zones under harsh environmental conditions is associated with exertional heat illness (EHI). However, the impact of a full-scale war on the incidence and severity of EHI in training settings remains insufficiently investigated. Materials and Methods: We analyzed EHI data obtained from the IDF Institute of Military Physiology database for three years (October 2022 to September 2025). The cohort included 174 soldiers diagnosed with EHI, stratified into three phases: Pre-War, Acute-War, and Late-War. Results: Despite massive deployment to combat zones, 93.1% of EHI cases occurred in training settings. Of the cohort, 46 (26.4%) were classified as exertional heat stroke (EHS) and 128 (73.6%) as less-severe EHI (LSEHI). The proportion of life-threatening EHS cases increased to 36.7% during the Acute-War phase, compared to 20.7% Pre-War and 21.4% Late-War (P < .05). Although insufficient sleep was the strongest predictor of EHS across the entire cohort (OR 2.75, 95% CI, 1.34-5.65), its prevalence remained stable across periods. In contrast, the Acute-War phase was distinguished by a significant surge in exceeding effort scale (P = .019), inadequate nutrition (P = .021), and late recognition of underperforming soldiers (P = .049), driving the specific spike in severity during this period. Conclusion: During the Acute-War phase (October 2023-September 2024), EHI cases occurred predominantly training-based and were markedly more severe. These findings suggest that a wartime context may influence risk perception and decision-making within training systems, contributing to the accumulation of multiple interacting risk factors and an increased likelihood of progression from LSEHI to EHS.
- 30 July 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (11-12) , e2443-e2450
Training in the Shadow of War: Exertional Heat Illness During the “Iron Swords” War
Introduction: High-intensity physical exertion in combat zones under harsh environmental conditions is associated with exertional heat illness (EHI). However, the impact of a full-scale war on the incidence and severity of EHI in training settings remains insufficiently investigated. Materials and Methods: We analyzed EHI data obtained from the IDF Institute of Military Physiology database for three years (October 2022 to September 2025). The cohort included 174 soldiers diagnosed with EHI, stratified into three phases: Pre-War, Acute-War, and Late-War. Results: Despite massive deployment to combat zones, 93.1% of EHI cases occurred in training settings. Of the cohort, 46 (26.4%) were classified as exertional heat stroke (EHS) and 128 (73.6%) as less-severe EHI (LSEHI). The proportion of life-threatening EHS cases increased to 36.7% during the Acute-War phase, compared to 20.7% Pre-War and 21.4% Late-War (P < .05). Although insufficient sleep was the strongest predictor of EHS across the entire cohort (OR 2.75, 95% CI, 1.34-5.65), its prevalence remained stable across periods. In contrast, the Acute-War phase was distinguished by a significant surge in exceeding effort scale (P = .019), inadequate nutrition (P = .021), and late recognition of underperforming soldiers (P = .049), driving the specific spike in severity during this period. Conclusion: During the Acute-War phase (October 2023-September 2024), EHI cases occurred predominantly training-based and were markedly more severe. These findings suggest that a wartime context may influence risk perception and decision-making within training systems, contributing to the accumulation of multiple interacting risk factors and an increased likelihood of progression from LSEHI to EHS.
- 18 May 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (9) , E2583-E2591
Residual Perforation Risk Assessment of Intratympanic Steroids via Tympanostomy Tube Versus Transtympanic Injections
Objectives/Hypothesis: To investigate the risk of residual tympanic membrane (TM) perforation after intratympanic (IT) steroidal treatment administered via transtympanic injection compared with trans‐tympanostomy tube (TyT).Study Design: Case series, systematic review and meta analysis.Methods: Data were retrieved from the medical files of an original cohort of all consecutive patients with sudden sensorineural hearing loss necessitating IT steroidal treatment in a tertiary medical center between January 1, 2016 and November 20, 2020. A systematic literature search of “MEDLINE” via “PubMed,” “Embase,” and “Web of Science” on comparable published cases was performed and meta‐analysis was established.Results: Eighteen studies describing 818 ears were included in the quantitative meta‐analysis in addition to a local cohort of 140 ears. The proportion of residual TM perforation was 1.11% and 1.14% (95% confidence interval: 0.01%–3.27% and 0.028%–2.38%) in the TyT and trans‐tympanic groups, respectively, suggesting no significant difference in residual TM perforation risk between these techniques.Conclusion: IT steroid therapy via trans‐TyT is not associated with more residual perforations than IT steroid therapy via transtympanic injections.Level of Evidence: NA Laryngoscope, 131:E2583–E2591, 2021
- 18 May 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (9) , E2583-E2591
Residual Perforation Risk Assessment of Intratympanic Steroids via Tympanostomy Tube Versus Transtympanic Injections
Objectives/Hypothesis: To investigate the risk of residual tympanic membrane (TM) perforation after intratympanic (IT) steroidal treatment administered via transtympanic injection compared with trans‐tympanostomy tube (TyT).Study Design: Case series, systematic review and meta analysis.Methods: Data were retrieved from the medical files of an original cohort of all consecutive patients with sudden sensorineural hearing loss necessitating IT steroidal treatment in a tertiary medical center between January 1, 2016 and November 20, 2020. A systematic literature search of “MEDLINE” via “PubMed,” “Embase,” and “Web of Science” on comparable published cases was performed and meta‐analysis was established.Results: Eighteen studies describing 818 ears were included in the quantitative meta‐analysis in addition to a local cohort of 140 ears. The proportion of residual TM perforation was 1.11% and 1.14% (95% confidence interval: 0.01%–3.27% and 0.028%–2.38%) in the TyT and trans‐tympanic groups, respectively, suggesting no significant difference in residual TM perforation risk between these techniques.Conclusion: IT steroid therapy via trans‐TyT is not associated with more residual perforations than IT steroid therapy via transtympanic injections.Level of Evidence: NA Laryngoscope, 131:E2583–E2591, 2021
- 21 April 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (9) , 2091-2097
Paper Patching Versus Watchful Waiting of Traumatic Tympanic Membrane Perforations: A Meta‐Analysis
Objectives/Hypothesis: The aim of the study was to investigate the healing rates, the restoration of hearing, and the time for complete healing of paper patching versus watchful waiting for traumatic tympanic membrane perforations (TTMPs).Study Design: Systematic review with meta analysis.Methods: Publications were selected by a search on “PubMed,” “Embase,” and “Web of Science.” A meta‐analysis of risk ratios for paper patching (intervention arm) and watchful waiting (control arm) was performed.Results: Five studies describing 393 TTMPs were included in the quantitative meta‐analysis. TTMP healing rates ranged between 84.2% and 95.2% in the intervention arm and between 76.7% and 84.8% in the control arm. The pooled risk ratio of healed TTMPs was significantly higher in the intervention arm than in the control arm (risk ratio: 1.12, 95% confidence interval: 1.04–1.21).Conclusions: TTMPs have high healing potential with and without intervention. The healing rate of paper patching was superior to that of watchful waiting alone.Level of Evidence: NA Laryngoscope, 131:2091–2097, 2021
- 21 April 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (9) , 2091-2097
Paper Patching Versus Watchful Waiting of Traumatic Tympanic Membrane Perforations: A Meta‐Analysis
Objectives/Hypothesis: The aim of the study was to investigate the healing rates, the restoration of hearing, and the time for complete healing of paper patching versus watchful waiting for traumatic tympanic membrane perforations (TTMPs).Study Design: Systematic review with meta analysis.Methods: Publications were selected by a search on “PubMed,” “Embase,” and “Web of Science.” A meta‐analysis of risk ratios for paper patching (intervention arm) and watchful waiting (control arm) was performed.Results: Five studies describing 393 TTMPs were included in the quantitative meta‐analysis. TTMP healing rates ranged between 84.2% and 95.2% in the intervention arm and between 76.7% and 84.8% in the control arm. The pooled risk ratio of healed TTMPs was significantly higher in the intervention arm than in the control arm (risk ratio: 1.12, 95% confidence interval: 1.04–1.21).Conclusions: TTMPs have high healing potential with and without intervention. The healing rate of paper patching was superior to that of watchful waiting alone.Level of Evidence: NA Laryngoscope, 131:2091–2097, 2021
- 20 April 2021
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 42 (7) , 1008-1013
The Actual Incidence and Types of Hearing Losses in Bullous Myringitis: Case Series and Systematic Review
Objective: To calculate the incidence of sensorineural hearing loss (SNHL; pure or as part of a mixed hearing loss, MHL) among bullous myringitis (BM) patients with a coexisting HL to assess whether steroidal treatment should be initiated even before the findings of a formal audiogram are available. Methods: Retrospective medical record review in a tertiary referral center and systematic review of the English literature. Results: The medical records of 81 patients with BM were retrieved among whom 50 patients (62%) had actually sustained a HL, although only 39/81 patients reported a HL when asked. Twenty-four patients had a MHL, 18 had a SNHL, and eight had a conductive HL (CHL). The systematic review included 106 ears: 17 had no HL, 53 had a MHL, 20 had a SNHL, and 16 had a CHL. The combined published and current results yielded a SNHL and MHL rates of 38/139 (27%) and 77/139 (55%), respectively of all BM patients with confirmed HL. Conclusion: BM is intuitively associated with a CHL resulting from the impeded function of the affected middle ear. Medical history and physical examination are not sufficient to exclude a SNHL in BM patients, and formal audiometry is mandatory for exclusion/confirmation in this setting. Nevertheless, steroidal treatment should not be delayed until the performance of formal audiometry because the actual rate of pure CHL in this setting is very low. Level of Evidence: 2
- 20 April 2021
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 42 (7) , 1008-1013
The Actual Incidence and Types of Hearing Losses in Bullous Myringitis: Case Series and Systematic Review
Objective: To calculate the incidence of sensorineural hearing loss (SNHL; pure or as part of a mixed hearing loss, MHL) among bullous myringitis (BM) patients with a coexisting HL to assess whether steroidal treatment should be initiated even before the findings of a formal audiogram are available. Methods: Retrospective medical record review in a tertiary referral center and systematic review of the English literature. Results: The medical records of 81 patients with BM were retrieved among whom 50 patients (62%) had actually sustained a HL, although only 39/81 patients reported a HL when asked. Twenty-four patients had a MHL, 18 had a SNHL, and eight had a conductive HL (CHL). The systematic review included 106 ears: 17 had no HL, 53 had a MHL, 20 had a SNHL, and 16 had a CHL. The combined published and current results yielded a SNHL and MHL rates of 38/139 (27%) and 77/139 (55%), respectively of all BM patients with confirmed HL. Conclusion: BM is intuitively associated with a CHL resulting from the impeded function of the affected middle ear. Medical history and physical examination are not sufficient to exclude a SNHL in BM patients, and formal audiometry is mandatory for exclusion/confirmation in this setting. Nevertheless, steroidal treatment should not be delayed until the performance of formal audiometry because the actual rate of pure CHL in this setting is very low. Level of Evidence: 2